TherapeuticsMD CEO on the switch to Nasdaq from NYSE

8:43 AM ET Mon, 9 Oct 2017

TherapeuticsMD CEO Robert Finizio discusses his company's transfer from listing on the NYSE to listing on the Nasdaq as well as why the pharma company has been successful with women's issues.